Pyrazolylaminopyridines as inhibitors of FAK

Details for Australian Patent Application No. 2009320144 (hide)

Owner GlaxoSmithKline LLC

Inventors Adams, Jerry Leroy; Faitg, Thomas H.; Johnson, Neil W.; Lin, Hong; Kasparec, Jiri; Mellinger, Mark; Peng , Xin; Xie, Ren

Agent Davies Collison Cave

Pub. Number AU-A-2009320144

PCT Pub. Number WO2010/062578

Priority 61/108,568 27.10.08 US; 61/242,432 15.09.09 US; 61/178,517 15.05.09 US

Filing date 27 October 2009

Wipo publication date 3 June 2010

International Classifications

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/062578 Priority application(s): WO2010/062578

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009320150-Wad with ignition chamber

2009320143-Clinical assessment scales and methods